# IBRUTINIB
> **ANDA214498** · Abbreviated New Drug Application (Generic) · Sponsor: ALVOGEN INC · Approved 2021-06-03
## Drug
- **FDA Application Number:** ANDA214498
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** IBRUTINIB
- **Generic name:** Ibrutinib
- **Active ingredients:** IBRUTINIB
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** ALVOGEN INC
- **First approval:** 2021-06-03
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214498)
---
*MORVS · CC0 1.0*